Aarti Drugs faces revenue decline amid API Market challenges in Q3 FY25
Aarti Drugs Limited, a Mumbai-based pharmaceutical company engaged in Active Pharmaceutical Ingredients (API), formulations, specialty chemicals, and intermediates, has reported a decline in revenue for ... Read More
Aarti Drugs launches dermatology product production at new Tarapur facility
Aarti Drugs Limited (NSE: AARTIDRUGS; BSE:524348), a Mumbai-based pharmaceutical powerhouse, has officially announced the start of its dermatology product production at its newly established facility ... Read More
Aarti Drugs Limited announces 6% YoY revenue growth in Q1 FY24
For the quarter ending 30th June 2023, Mumbai-based pharmaceutical company, Aarti Drugs Limited, announced its audited financial results, reporting a 6% year-on-year (YoY) growth in ... Read More